Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience

QR Code

Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience

Saved in:

Bibliographic Details
Main Authors:	Andrea Angeletti, Gianluca Caridi, Xhuliana Kajana, Carolina Bigatti, Agnese Spennacchio, Decimo Silvio Chiarenza, Gabriele Mortari, Paolo Cravedi, Enrico E. Verrina
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024925003894
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
by: Felicitas E. Hengel, et al.
Published: (2025-08-01)

Organising Pneumonia in a Patient Following Obinutuzumab for Follicular Lymphoma
by: Viral Nanda, et al.
Published: (2025-06-01)

The differential expression of MAGI2 in glomerulopathies and its application as a molecular discriminator of podocytopathies
by: Florian Siegerist, et al.
Published: (2025-06-01)

What’s new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
by: Astrid Weins, et al.
Published: (2025-07-01)

Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial
by: Li XQ, et al.
Published: (2025-07-01)

Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice
by: Anna Maria Frustaci, et al.
Published: (2025-06-01)

Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 studyResearch in context
by: Tomasz Wróbel, et al.
Published: (2025-08-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-05-01)

Rituximab Induced Lichen Planus
by: Anand Mannu, et al.
Published: (2025-07-01)

The Low Tiber Valley Terraces
by: Roberto Mortari
Published: (2005-12-01)

Susac syndrome: The effectiveness of Rituximab monotherapy
by: T. V. Beketova
Published: (2023-06-01)

Rituximab in the management of systemic lupus erythematosus
by: Adrian Levitsky, et al.
Published: (2013-06-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Livedoid vasculopathy: experience in using rituximab
by: Yuri Vladimirovich Muravyev, et al.
Published: (2011-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Livedoid vasculopathy: experience in using rituximab
by: Tatyana Valentinovna Beketova, et al.
Published: (2011-08-01)

USE OF RITUXIMAB IN AUTOIMMUNE DISEASES: NEW ASPECTS
by: Dmitry Evgenyevich Karateyev
Published: (2010-09-01)

RITUXIMAB: NEW POTENTIALITIES OF THERAPY FOR RHEUMATOID ARTHRITIS
by: D E Karateev, et al.
Published: (2008-12-01)

Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01)

Rituximab in the treatment of systemic sclerosis. Literature review
by: L. A. Garzanova
Published: (2023-08-01)

Effect of rituximab on heart involvement in systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2019-01-01)

Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01)

EXPERIENCE OF TREATMENT WITH RITUXIMAB IN PATIENT WITH JUVENILE POLYARTERITIS
by: E.I. Alexeeva, et al.
Published: (2011-03-01)

Uso de anticuerpos monoclonales anti-CD20 (rituximab) en paciente con pénfigo vulgar grave
by: Carolina Concha, et al.
Published: (2019-02-01)

Bruno Munari: comunicare attraverso la grafica
by: Barbara Messina, et al.
Published: (2025-06-01)

Pénfigo eritematoso severo asociado a falla cutánea tratado exitosamente con rituximab
by: Bruny Carolina Llamas Castellanos, et al.
Published: (2024-07-01)

EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01)

Validation of Enzyme Immunoassay for Preclinical Pharmacokinetic Trials of Rituximab
by: V. V Pisarev, et al.
Published: (2019-06-01)

The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2023-08-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

THE EFFICACY AND SAFETY OF RITUXIMAB IN RHEUMATOID ARTHRITIS: NEW EVIDENCE
by: D. A. Kusevich, et al.
Published: (2017-09-01)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
by: David Jayne, et al.
Published: (2019-06-01)

Rituximab for children with immune thrombocytopenia: a systematic review.
by: Yi Liang, et al.
Published: (2012-01-01)

Rituximab in Pemphigus - Exploring the Less Frequently Travelled Terrains
by: Raghavendra Rao
Published: (2025-07-01)

Religar saberes: uma jornada pela obra «Este é o meu corpo: para uma teologia da motricidade humana»
by: Katia Simone Martins Mortari
Published: (2025-07-01)

Rituximab in pemphigus and pemphigoid patients: Treatment outcomes and safety profile - A 6-year tertiary center study
by: Sivakanth Gopakumar, et al.
Published: (2025-07-01)

Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients
by: Tamather Almandeel, et al.
Published: (2025-06-01)

Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
by: Nikolay N. Murashkin, et al.
Published: (2022-11-01)

Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
by: Evgeni Lvovich Nasonov
Published: (2009-12-01)